Funding for this research was provided by:
National Cancer Institute (5-R01-CA133004)
Text and Data Mining valid from 2018-05-31
Received: 16 June 2016
Accepted: 13 May 2018
First Online: 31 May 2018
Ethics approval and consent to participate
: The University of Pennsylvania and Massachusetts General Hospital Institutional Review Boards approved the study, and considered completion of a questionnaire as implicit informed consent.
: Dr. Armstrong has a consulting role with GlaxoSmithKline. The remaining authors have no conflicts of interest to disclose.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.